Search Results
Search for other papers by A. T. HOLDER in
Google Scholar
PubMed
Search for other papers by M. A. PREECE in
Google Scholar
PubMed
Search for other papers by M. WALLIS in
Google Scholar
PubMed
Serum from adrenalectomized rats was equipotent with serum from non-adrenalectomized animals when measured in a rat cartilage somatomedin bioassay. Extraction with butanol of sera from normal or adrenalectomized rats reduced their potency in the somatomedin bioassay rather than increasing it as has been previously reported. Butanol-soluble inhibitors of cartilage metabolism were found in sera from both normal and adrenalectomized rats. Cortisol and corticosterone, up to mildly supraphysiological levels, were found to have no effect on basal cartilage metabolism. These results suggest that physiological levels of glucocorticoids do not exert an inhibitory effect on the uptake of 35SO4 2− into immature rat cartilage. Since butanol-soluble inhibitors of cartilage metabolism were found in adrenalectomized rat serum it is unlikely that these substances are glucocorticoids.
Search for other papers by T. A. Yarney in
Google Scholar
PubMed
Search for other papers by J. Z. Kendall in
Google Scholar
PubMed
Search for other papers by G. C. B. Randall in
Google Scholar
PubMed
ABSTRACT
The ontogeny of fetal lung glucocorticoid receptors and their regulation by the fetal pituitary, adrenal and thyroid gland during lung maturation were investigated. Sites with a specificity typical of glucocorticoid receptors were detectable in lung cytosol, with the order of potency of steroids being dexamethasone > cortisol > corticosterone > 11- -deoxycorticosterone > progesterone > 17α-hydroxyprogesterone > oestradiol -17β ≃ testosterone ≃ androstenedione ≃ oestrone. The binding affinity for [3H]dexamethasone was high (K d = 0·23–0·60 nmol/l) and showed an age-related decrease during the perinatal period when cortisol levels were high. After charcoal treatment of the cytosol, however, a decrease in binding affinity was not as clearly evident. The K d decreased following hypophysectomy of fetuses; thyroidectomy had no significant effect. The concentration of glucocorticoid receptors was high from day 82 to day 100 of gestation (1437 fmol/mg protein) and declined progressively to a lower value at term and following birth (660 fmol/mg protein). Hypophysectomy, but not thyroidectomy, prevented the age-related decline in receptor concentration. Lung glycogen content declined with fetal ageing in association with increases in plasma concentrations of cortisol and thyroxine and with changes in K d and B max, but appeared to be more closely associated with concentrations of thyroxine. Hypophysectomy of fetuses decreased concentrations of both cortisol and thyroxine and prevented the depletion of lung glycogen content. Preliminary results from thyroidectomized fetuses showed decreases in plasma thyroxine and lung glycogen content compared with day-82 fetuses. Plasma cortisol levels, however, were consistent with a fetal age of 113 days. The effects of thyroxine on lung glycogen depletion, therefore, appear to occur, at least in part, through a pathway independent of glucocorticoid receptors.
Journal of Endocrinology (1990) 127, 341–349
Search for other papers by M. Kurokawa in
Google Scholar
PubMed
Search for other papers by V. P. Michelangeli in
Google Scholar
PubMed
Search for other papers by D. M. Findlay in
Google Scholar
PubMed
ABSTRACT
When T47D cells were maintained long term in medium containing 0·1 μmol cortisol/l, calcitonin receptor (CTR) expression was stimulated compared with the very low levels of binding in untreated cells grown from frozen stocks. The time-course of the appearance of CTR following treatment with cortisol was slow, requiring up to 3 weeks of continuous exposure of the cells to the steroid. Binding capacity of control cells also increased slowly with time in culture, but after 3 months was only 20–30% of that in cells continuously treated with cortisol. Removal of cortisol resulted in rapid loss of CTR so that binding was reduced to ∼ 50% of treated cell levels within 1 week of removal. Scatchard analysis of the binding data showed that the increased binding capacity induced by cortisol was due solely to a change in average receptor number per cell, with no change in receptor affinity. That this induction of CTR was due to a glucocorticoid effect was shown by the more rapid (< 96 h) and more potent (< 1 nmol/l) action of dexamethasone than of cortisol. In addition, induction was inhibited by the glucocorticoid inhibitor RU486. The induced receptors were shown to be functional, since salmon calcitonin-stimulated adenylate cyclase was induced in parallel with CTR. These results indicate that glucocorticoids are potential regulators of the CTR.
Journal of Endocrinology (1991) 130, 321–326
Search for other papers by N. Torres in
Google Scholar
PubMed
Search for other papers by M. Fanelli in
Google Scholar
PubMed
Search for other papers by A. L. Alvarez in
Google Scholar
PubMed
Search for other papers by D. Santajuliana in
Google Scholar
PubMed
Search for other papers by S. Finkielman in
Google Scholar
PubMed
Search for other papers by C. J. Pirola in
Google Scholar
PubMed
ABSTRACT
Betamethasone was administered on alternate days to rats, and the role of the central cholinergic system in the development of hypertension assessed. After 15 days of treatment the systolic blood pressure of treated rats was significantly higher than that of control rats. Peripheral administration of atropine but not of methyl atropine reduced systolic pressure in glucocorticoid-treated rats and had no effect in controls. Therefore, [3H]quinuclidinyl benzylate binding, sodium-dependent high-affinity choline uptake and choline acetyltransferase studies were performed in the septal area, anteroventrolateral medulla (AVLM), anterior hypothalamic preoptic area (AH/PO) and hypothalamus. The density of muscarinic receptors was increased in the hypothalamus and AVLM of treated rats without significant changes in affinity. Choline acetyltransferase activity significantly decreased in the AVLM and increased in the AH/PO. In addition, a decrease in the hypothalamus and an increase in the AH/PO of sodium-dependent high-affinity choline uptake was observed in glucocorticoid-treated rats. These results suggest the presence of an enhanced muscarinic cholinergic activity in several brain nuclei in rats with glucocorticoid-induced hypertension. This activation could be due to pre- and post-synaptic hypersensitivity.
Journal of Endocrinology (1991) 129, 269–274
Search for other papers by K. W. Kan in
Google Scholar
PubMed
Search for other papers by R. L. Cruess in
Google Scholar
PubMed
ABSTRACT
In order to assess glucocorticoid actions on fetal cartilage development, [3H]dexamethasone binding site levels in fetal bovine cartilaginous tissues from long bones were measured, using a whole cell assay at 37 °C. Displaceable [3H]dexamethasone binding in epiphysial growth cartilage was maximal (16·2 fmol/106 cells) in fetuses of 10–15 cm crown–rump length (CR), and declined to 22% of the maximum in fetuses of 20–30 cm CR. Subsequently, [3H]dexamethasone binding rose to a plateau (13·0 fmol/106 cells) in fetuses of 30–80 cm CR and declined in those of 80–100 cm CR. When measured in growth plate cartilage, [3H]dexamethasone binding was significantly higher in fetuses of 40–80 cm CR (39 fmol/106 cells) than in those of 80–100 cm CR. There was no significant change of [3H]dexamethasone binding affinities in epiphysial chondrocytes of 5–100 cm CR fetuses or in growth plate chondrocytes of 40–100 cm CR fetuses.
These results demonstrate that fetal cartilaginous tissues during development possess varying cellular levels of glucocorticoid binding and may thus have temporal changes in sensitivity to glucocorticoid hormones.
J. Endocr. (1986) 110, 257–262
Search for other papers by D. B. ENDRES in
Google Scholar
PubMed
Search for other papers by R. J. MILHOLLAND in
Google Scholar
PubMed
Search for other papers by F. ROSEN in
Google Scholar
PubMed
The effects in rats of adrenalectomy, hypophysectomy, ovariectomy or combinations of these operations on the concentrations of glucocorticoid receptors in the cytosol of liver and thymus were measured. The concentrations of glucocorticoid receptors were lower in cytosols from liver and thymus of female than of male rats. After adrenalectomy, there was a significant increase in the concentrations of receptors measured in the cytoplasm from the liver and thymus of female rats and from the liver of male rats. After adrenalectomy or hypophysectomy, there was no sex difference in the concentrations of glucocorticoid receptors in cytosols of liver or thymus. After ovariectomy, the concentration of receptors in cytosols from the thymus, but not from the liver, increased. Ovariectomized rats responded to adrenalectomy in the same way as intact male rats. The different responses shown by male and female rats to endocrine manipulation probably depend upon associated changes in plasma corticosterone concentrations which are influenced by the ovary. Differences in response between the liver and thymus probably reflect a preferential distribution of corticosterone to the liver rather than to the thymus.
Search for other papers by R. F Selden in
Google Scholar
PubMed
Search for other papers by J. S. Yun in
Google Scholar
PubMed
Search for other papers by D. D. Moore in
Google Scholar
PubMed
Search for other papers by M. E. Rowe in
Google Scholar
PubMed
Search for other papers by M. A. Malia in
Google Scholar
PubMed
Search for other papers by T. E. Wagner in
Google Scholar
PubMed
Search for other papers by H. M. Goodman in
Google Scholar
PubMed
ABSTRACT
A mouse metallothionein-I/human growth hormone fusion gene was microinjected into fertilized mouse eggs, the embryos were implanted into pseudopregnant foster mothers, and the offspring analysed. Five of twenty-six mice born after one series of injections contained from one to eight copies of the fusion gene stably integrated into their genomes and had human growth hormone in their serum. When several of these transgenic mice and transgenic offspring were treated with glucocorticoids, serum growth hormone levels were elevated from 1·5- to 6·3-fold. A fourfold induction in fusion gene mRNA in the liver of one of the five mice was also observed after treatment with glucocorticoids. When the fusion gene was transiently transfected into mouse L cells, dexamethasone caused a three- to fourfold induction of fusion gene mRNA and secreted human growth hormone. A deletion analysis of regulatory elements required for inducibility in L cells shows that DNA sequences responsible for the observed inductions are located within the transcribed region of the human growth hormone gene. However, a previously described glucocorticoid receptor binding site in the first intron of the gene is not required for response to the hormone.
Journal of Endocrinology (1989) 122, 49–60
Search for other papers by AG Gunin in
Google Scholar
PubMed
The aim of this study was to examine the effect of long-term treatment with glucocorticoids on the uterine response to oestradiol. Ovariectomized rats were treated with crystal triamcinolone acetonide (0.1 mg/100 g, i.m.) or saline (0.1 ml/100 g i.m.) for 29 days. Over this period five injections were administered, one per week. On the second day after the last triamcinolone injection, rats were treated with a single injection of oestradiol dipropionate (5 micrograms/100 g, s.c.) or vehicle (olive oil, 0.1 ml/100 g, s.c.). The effects of oestradiol in the uterus were determined by measuring mitotic index, bromodeoxyuridine (BrdU)-labelling index (BrdU was injected 2 h before the rats were killed; 2 mg/100 g, i.p.), and proliferating cell nuclear antigen (PCNA)-labelling index 24, 36 and 48 h after the injection of oestradiol or vehicle. Long-term treatment with glucocorticoids resulted in dissimilar changes in oestradiol-induced proliferation in epithelial and connective-tissue (stroma) components of the uterus. In luminal and glandular epithelia, there was an initial reduction in proliferation at 24 h, followed by an increase at 36 h and a further reduction at 48 h after the oestradiol injection. In stromal cells of the endometrium, triamcinolone treatment caused a large constant increase in oestradiol-induced proliferation throughout the experiment. The glucocorticoid treatment had no effect on the parameters without oestradiol administration.
Search for other papers by MJ Nyirenda in
Google Scholar
PubMed
Search for other papers by LA Welberg in
Google Scholar
PubMed
Search for other papers by Seckl JR in
Google Scholar
PubMed
In a previous study, we showed that exposure of rats to dexamethasone (Dex) selectively in late pregnancy produces permanent induction of hepatic phosphoenolpyruvate carboxykinase (PEPCK) expression and hyperglycaemia in the adult offspring. The mechanisms by which glucocorticoids cause this programming are unclear but may involve direct actions on the fetus/neonate, or glucocorticoids may act indirectly by affecting maternal postnatal nursing behaviour. Using a cross-fostering paradigm, the present data demonstrate that switching the offspring at birth from Dex-treated dams to control dams does not prevent induction of PEPCK or hyperglycaemia. Similarly, offspring born to control dams but reared by Dex-treated dams from birth maintain normal glycaemic control. During the neonatal period, injection of saline per se was sufficient to cause exaggeration in adult offspring responses to an oral glucose load, with no additional effect from Dex. However, postnatal treatment with either saline or Dex did not alter hepatic PEPCK activity. Prenatal Dex permanently raised basal plasma corticosterone levels, but under stress conditions there were no differences in circulating corticosterone levels. Likewise, Dex-exposed rats had similar plasma catecholamine concentrations to control animals. These findings show that glucocorticoids programme hyperglycaemia through mechanisms that operate on the fetus or directly on the neonate, rather than via effects that alter maternal postnatal behaviour during the suckling period. The hyperglycaemic response does not appear to result from abnormal sympathoadrenal activity or hypothalamic-pituitary-adrenal response during stress.
Search for other papers by Samuel Richard Heaselgrave in
Google Scholar
PubMed
Search for other papers by Silke Heising in
Google Scholar
PubMed
Search for other papers by Stuart Andrew Morgan in
Google Scholar
PubMed
Search for other papers by David M Cartwright in
Google Scholar
PubMed
Search for other papers by Michael S Sagmeister in
Google Scholar
PubMed
Search for other papers by Rowan Hardy in
Google Scholar
PubMed
Search for other papers by Craig L Doig in
Google Scholar
PubMed
Search for other papers by Nicholas Morton in
Google Scholar
PubMed
Search for other papers by Kostas Tsintzas in
Google Scholar
PubMed
Search for other papers by Gareth G Lavery in
Google Scholar
PubMed
Systemic glucocorticoid excess causes several adverse metabolic conditions, most notably Cushing’s syndrome. These effects are amplified by the intracellular enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Here we determined the less well characterised effects of glucocorticoid excess, and the contribution of 11β-HSD1 amplification, on metabolic rate in mice. Male and female C57BL/6J (wild type, WT) and 11β-HSD1 knock out (11β-HSD1KO) mice were treated with high-dose corticosterone or a vehicle control for 3 weeks. Indirect calorimetry was conducted during the final week of treatment, with or without fasting, to determine the impact on metabolic rate. We found that corticosterone treatment elevated metabolic rate and promoted carbohydrate utilisation primarily in female WT mice, with effects more pronounced during the light phase. Corticosterone treatment also resulted in greater fat accumulation in female WT mice. Corticosterone induced hyperphagia was identified as a likely causal factor altering the respiratory exchange ratio (RER) but not energy expenditure (EE). Male and female 11β-HSD1KO mice were protected against these effects. We identify novel metabolic consequences of sustained glucocorticoid excess, identify a key mechanism of hyperphagia and demonstrate that 11β-HSD1 is required to manifest the full metabolic derangement.
